Ren X, Manzanares L, Piccolo E, Urbanczyk J, Sullivan D, Yalom L
J Clin Invest. 2023; 133(15).
PMID: 37261911
PMC: 10378177.
DOI: 10.1172/JCI170733.
Barta B, Onhausz B, Al Doghmi A, Szalai Z, Balazs J, Bagyanszki M
World J Diabetes. 2023; 14(1):48-61.
PMID: 36684383
PMC: 9850801.
DOI: 10.4239/wjd.v14.i1.48.
Vugler A, OConnell J, Nguyen M, Weitz D, Leeuw T, Hickford E
Front Pharmacol. 2022; 13:1037983.
PMID: 36467083
PMC: 9709720.
DOI: 10.3389/fphar.2022.1037983.
Skartsis N, Ferreira L, Tang Q
Front Immunol. 2022; 13:1042622.
PMID: 36466853
PMC: 9708889.
DOI: 10.3389/fimmu.2022.1042622.
Yang J, Ran M, Li H, Lin Y, Ma K, Yang Y
Front Mol Neurosci. 2022; 15:1013933.
PMID: 36353359
PMC: 9637688.
DOI: 10.3389/fnmol.2022.1013933.
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors.
Sander C, Rush E, Shi J, Arantes L, Tesi R, Ross M
J Transl Med. 2022; 20(1):331.
PMID: 35879777
PMC: 9310383.
DOI: 10.1186/s12967-022-03538-w.
Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer.
Li M, Zhang X, Bai X, Liang T
Front Oncol. 2022; 12:862154.
PMID: 35494080
PMC: 9048045.
DOI: 10.3389/fonc.2022.862154.
An Overview of The Role of Tumor Necrosis Factor-Alpha in Epileptogenesis and Its Terapeutic Implications.
Michev A, Orsini A, Santi V, Bassanese F, Veraldi D, Brambilla I
Acta Biomed. 2022; 92(S4):e2021418.
PMID: 35441606
PMC: 9179056.
DOI: 10.23750/abm.v92iS4.12667.
The Signaling Pathway of TNF Receptors: Linking Animal Models of Renal Disease to Human CKD.
Lousa I, Reis F, Santos-Silva A, Belo L
Int J Mol Sci. 2022; 23(6).
PMID: 35328704
PMC: 8950598.
DOI: 10.3390/ijms23063284.
Dichotomous Role of Tumor Necrosis Factor in Pulmonary Barrier Function and Alveolar Fluid Clearance.
Lucas R, Hadizamani Y, Enkhbaatar P, Csanyi G, Caldwell R, Hundsberger H
Front Physiol. 2022; 12:793251.
PMID: 35264975
PMC: 8899333.
DOI: 10.3389/fphys.2021.793251.
Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells.
Kitaura H, Marahleh A, Ohori F, Noguchi T, Nara Y, Pramusita A
Int J Mol Sci. 2022; 23(3).
PMID: 35163403
PMC: 8835906.
DOI: 10.3390/ijms23031481.
Cytokine Receptors-Regulators of Antimycobacterial Immune Response.
Druszczynska M, Godkowicz M, Kulesza J, Wawrocki S, Fol M
Int J Mol Sci. 2022; 23(3).
PMID: 35163035
PMC: 8835057.
DOI: 10.3390/ijms23031112.
The TNF-α/TNFR2 Pathway: Targeting a Brake to Release the Anti-tumor Immune Response.
Moatti A, Cohen J
Front Cell Dev Biol. 2021; 9:725473.
PMID: 34712661
PMC: 8546260.
DOI: 10.3389/fcell.2021.725473.
Antileukemic Natural Product Induced Both Apoptotic and Pyroptotic Programmed Cell Death and Differentiation Effect.
Leu W, Chang H, Chen I, Guh J, Chan S
Int J Mol Sci. 2021; 22(20).
PMID: 34681898
PMC: 8538678.
DOI: 10.3390/ijms222011239.
Metabolic Messengers: tumour necrosis factor.
Sethi J, Hotamisligil G
Nat Metab. 2021; 3(10):1302-1312.
PMID: 34650277
DOI: 10.1038/s42255-021-00470-z.
Angiotensin II-induced natriuresis is attenuated in knockout mice lacking the receptors for tumor necrosis factor-α.
Majid D, Castillo A
Physiol Rep. 2021; 9(15):e14942.
PMID: 34337896
PMC: 8326895.
DOI: 10.14814/phy2.14942.
LncRNA NEAT1 mediates intestinal inflammation by regulating TNFRSF1B.
Pan S, Liu R, Wu X, Ma K, Luo W, Nie K
Ann Transl Med. 2021; 9(9):773.
PMID: 34268386
PMC: 8246228.
DOI: 10.21037/atm-21-34.
TNFR2 is required for RIP1-dependent cell death in human leukemia.
Aguade-Gorgorio J, McComb S, Eckert C, Guinot A, Marovca B, Mezzatesta C
Blood Adv. 2020; 4(19):4823-4833.
PMID: 33027529
PMC: 7556136.
DOI: 10.1182/bloodadvances.2019000796.
Biomarkers for Temporomandibular Disorders: Current Status and Future Directions.
Zwiri A, Al-Hatamleh M, W Ahmad W, Asif J, Khoo S, Husein A
Diagnostics (Basel). 2020; 10(5).
PMID: 32429070
PMC: 7277983.
DOI: 10.3390/diagnostics10050303.
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer.
Mercogliano M, Bruni S, Elizalde P, Schillaci R
Front Oncol. 2020; 10:584.
PMID: 32391269
PMC: 7189060.
DOI: 10.3389/fonc.2020.00584.